Osteosarkoma Dokter Terbaik di Turquia - TOP-29 dokter

• Dr. Bülent Karagöz berspesialisasi dalam pengobatan Osteosarcoma.
• Menggunakan pembedahan, kemoterapi, dan terapi target untuk Osteosarcoma.
• Terlatih secara internasional, termasuk pengalaman di Komando KFOR NATO.
• Anggota aktif Asosiasi Onkologi Medis Turki.
• Menawarkan konsultasi online untuk pasien dengan Osteosarcoma.
• Berbicara bahasa Turki dan Inggris, membantu basis pasien yang lebih luas.
• Lebih dari 40 publikasi dalam penelitian kanker, berkontribusi pada pengetahuan onkologi.

Dia telah bekerja sebagai dokter spesialis penyakit dalam dan spesialis onkologi medis di Pusat Medis Anadolu sejak tahun 2021.
 

• Spesialis dalam perawatan Osteosarkoma, menggunakan pembedahan, kemoterapi, dan radiasi.
• Terlatih secara internasional di USA di MD Anderson Cancer Center.
• Tersertifikasi oleh Hacettepe University Cancer Institute.
• Anggota organisasi medis terkemuka untuk keahlian onkologi.
• Menawarkan konsultasi online untuk pasien Osteosarkoma global.
• Mampu berkomunikasi dalam Bahasa Inggris dan Turki untuk komunikasi pasien yang beragam.
• Dikenal karena perawatan komprehensif dalam manajemen kanker tulang yang agresif.

• Dr. Yesim Yildirim berspesialisasi dalam pengobatan Osteosarkoma.
• Metode pengobatan: pembedahan, kemoterapi, terapi target.
• Praktik internasional di AS, Turki, Israel, dan Inggris.
• Sertifikasi dari European Society of Medical Oncology (ESMO).
• Anggota European Society of Medical Oncology dan European School of Oncology.
• Konsultasi pasien Osteosarkoma secara daring.
• Bahasa: Inggris, Rusia (tingkat B1), Turki.

Prof. Hale Başak Çağlar adalah seorang direktur onkologi radiasi dan ahli dalam mengobati kanker payudara, paru-paru, pankreas, prostat, dan tulang. Beliau sangat berkualifikasi, dengan pendidikan yang diperoleh dari Universitas Gazi, Universitas Marmara, dan Universitas Medipol, serta merupakan anggota dari berbagai asosiasi, seperti American Society for Therapeutic Radiation Oncology, European Society for Therapeutic Radiation Oncology, European Organisation for Research and Treatment of Cancer, dan Radiosurgery Society.

Pendidikan & Pelatihan

1997 hingga 2003
Istanbul University, Cerrahpaşa Medical School
Istanbul, Turki
Gelar: Dokter Medis (M.D.)

2003 hingga 2010
Taksim Education and Research Hospital
Istanbul, Turki
Residensi: Ortopedi dan Traumatologi

2010 hingga 2017
Baltalimanı Bone Diseases Education and Training Hospital
Istanbul, Turki
Jabatan: Spesialis Ortopedi dan Traumatologi

2017 – Sekarang
Istanbul Aydın University, Faculty of Medicine
Departemen: Ortopedi dan Traumatologi
Jabatan: Anggota Fakultas

Sertifikasi Ortopedi

2010
Dewan Ortopedi dan Traumatologi Turki
Istanbul, Turki

2014
Dewan Ortopedi dan Traumatologi Eropa (EBOT)

Keanggotaan Nasional

-Asosiasi Medis Turki

-Perhimpunan Bedah Ortopedi dan Traumatologi Turki

-Turkish AO (Arbeitsgemeinschaft für Osteosynthesefragen)

-FEBOT (Fellow of the European Board of Orthopaedics and Traumatology)

Publikasi di Jurnal Internasional Terakreditasi

A.1 Arıkan Y, Yavuz U, Lapcin O, Sökücü S, Özkan B, Kabukçuoğlu Y.
Ablasi radiofrekuensi perkutan untuk osteoid osteoma dengan panduan fluoroskopi tiga dimensi.
J Orthop Surg (Hong Kong). 2016.

A.2 Özcan Ç, Sökücü S, Beng K, Çetinkaya E, Demir B, Kabukçuoğlu YS.
Studi komparatif prospektif dari dua metode fiksasi setelah osteotomi korektif femur distal untuk deformitas valgus; paku intrameduler retrograde versus sistem pelat stabilisasi invasif minimal.
Int Orthop. 2016.

A.3 Karakoyun O, Sökücü S, Erol MF, Kucukkaya M, Kabukçuoğlu YS.
Penggunaan paku tulang magnetik untuk pemanjangan femur dan tibia.
J Orthop Surg (Hong Kong). 2016.

A.4 Balioğlu MB, Albayrak A, Atıcı Y, Sökücü S, Tacal MT, Kaygusuz MA.
Efek reseksi lokal sederhana terhadap nyeri dan kurva skoliosis pada pasien dengan skoliosis sekunder akibat osteoid osteoma dan osteoblastoma di tulang belakang.
Acta Orthop Traumatol Turc. 2016.

A.5 Sökücü S, Aycan OE, Arıkan Y, Kabukçuoğlu YS.
Proliferasi osteokondromatosa paradoxial kongenital di lokasi dan usia yang tidak biasa: laporan kasus.
Acta Orthop Traumatol Turc. 2016.

A.6 Bilgili F, Kılıç A, Sökücü S, Parmaksızoğlu A, Çepni K, Kabukçuoğlu Y.
Analisis retrospektif dari fraktur tibia tipe AO 42A–B yang dirawat dengan pelat terkunci perkutan dan pemakuan intrameduler.
Ulus Travma Acil Cerrahi Derg. 2016.

A.7 Özcan Ç, Sökücü S, Beng K, Çetinkaya E, Demir B, Kabukçuoğlu Y.
Studi komparatif prospektif dari dua metode fiksasi setelah osteotomi korektif femur distal untuk deformitas valgus; paku intrameduler retrograde versus sistem pelat stabilisasi invasif minimal.
Int Orthop. 2016.

A.8 Cetinkaya E, Yalcinkaya M, Sökücü S, Polat A, Ozkaya U, Parmaksizoglu A.
Kilektomi sebagai pilihan perawatan bedah lini pertama menghasilkan hasil fungsional yang baik pada hallux rigidus grade III.
J Am Podiatr Med Assoc. 2016.

A.9 Sökücü S, Menges O, Çetinkaya E, Parmaksızoğlu A, Kabukçuoğlu Y.
Pengobatan fraktur klavikula segmen tengah kominutif dengan fiksasi pelat menggunakan teknik penyangga.
Acta Orthop Traumatol Turc. 2014.

A.10 Sökücü S, Karakoyun O, Arıkan Y, Küçükkaya M, Kabukçuoğlu Y.
Efisiensi Taylor spatial frame dalam pengobatan Kelainan sekitar lutut.
Acta Orthop Traumatol Turc. 2013.

A.11 Küçükkaya M, Karakoyun Ö, Sökücü S, Soydan R.
Pemanjangan femur dan koreksi deformitas menggunakan paku Fitbone yang dapat diperpanjang secara motorik.
J Orthop Sci. 2014. 

A.12 Yalcinkaya M, Sökücü S, Erdoğan S, Kabukçuoğlu Y.
Penggunaan torniket dalam bedah ortopedi: studi survei deskriptif di antara ahli bedah ortopedi dan residen di Istanbul.
Acta Orthop Traumatol Turc. 2014.

A.13 Sökücü S, Demir B, Lapcin O, Yavuz U, Kabukçuoğlu Y.
Pengukuran parameter pemasangan Taylor Spatial Frame secara perioperatif versus pascaoperasi.
Acta Orthop Traumatol Turc. 2014.

A.14 Yavuz U, Sökücü S, Demir B, Özer D, Özcan Ç, Kabukçuoğlu Y.
Fusi subtalar isolasi untuk fraktur kalkaneus intra-artikular yang diabaikan dan menyakitkan.
Acta Orthop Traumatol Turc. 2014.

A.15 Yalcinkaya M, Yavuz U, Sökücü S, Chen C-Y, Lin K-C.
Dampak puncak paku dan titik pemasukan terhadap nyeri lutut anterior setelah pemakuan intrameduler tibial.
Orthopedics. 2014.

A.16 Yavuz U, Sökücü S, Demir B, Yıldırım T, Özcan Ç, Kabukçuoğlu Y.
Perbandingan fiksasi paku intrameduler atau plat pada fraktur diafisial tibial distal dekat dengan mortise.
Turk J Trauma Emerg Surg. 2014.

A.17 Karakoyun Ö, Küçükkaya M, Sökücü S.
Distraktor kinetik skeletal intrameduler dalam pemanjangan ekstremitas bawah.
Acta Orthop Traumatol Turc. 2014.

A.18 Gül M, Yavuz U, Sökücü S, Çetinkaya E, Arıkan Y, Kabukçuoğlu Y.
Metode fleksi-adduksi-rotasi eksternal untuk dislokasi bahu.
Acta Orthop Traumatol Turc. 2014.

A.19 Yavuz U, Sökücü S, Demir B, Akpınar E, Lapçin O, Atıcı Y, Kabukçuoğlu Y.
Fraktur stres yang tidak biasa pada seorang pemanah dengan hipofosfatasia.
Case Reports in Orthopedics. 2013.

A.20 Demir B, Sökücü S, Özden E, Yavuz U, Duman S, Kabukçuoğlu Y.
Teknik aplikasi baru fiksator sirkular untuk pengobatan fraktur tibia terbuka: teknik fiksator sirkular-bergantung.
Turk J Trauma Emerg Surg. 2013.

Publikasi di Jurnal Nasional Terakreditasi 

D.1 Kabukcuoglu Y, Yalcinkaya M, Sokucu S.
Pentahapan dan prinsip pengobatan bedah pada tumor tulang ganas.
Jurnal TOTBID. 2014.

D.2 Yavuz U, Sokucu S, Demir B, Yalcinkaya M, Cetinkaya E, Coskun M, Kabukcuoglu Y.
Evaluasi kebutuhan radiografi rutin pada pasien dengan trauma pergelangan kaki menggunakan Aturan Ottawa.
Jurnal Medis Göztepe. 2013.

D.3 Yavuz U, Bayhan AI, Atici Y, Sokucu S, Kargin D, Uzun M.
Prevalensi anomali tulang belakang lumbar yang terdeteksi secara radiografis pada populasi pria.
Jurnal Bedah Tulang Belakang Turki. 2013.

D.4 Beng K, Lapcin O, Sokucu S, Ozkazanli G, Kabukcuoglu YS, Parmaksizoglu AS.
Pengukuran Jarak Puncak pada pasien dengan fraktur femur intertrokanterik yang dirawat dengan sekrup pinggul dinamis 135° dan dampaknya pada hasil.
Jurnal Pelatihan dan Penelitian Kartal. 2013.

D.5 Atici Y, Albayrak A, Tacal TM, Sokucu S, Beng K, Sari S, Kaygusuz MA.
Teknik Tulang Rusuk Titanium Prostetik yang dapat Diperpanjang Vertikal (VEPTR) dalam pengobatan skoliosis onset dini: Pengaruhnya terhadap koreksi deformitas tulang belakang, pertumbuhan tulang belakang, keseimbangan sagital dan koronal, serta keselarasan bahu.
Jurnal Bedah Tulang Belakang Turki. 2012.

D.6 Gul M, Sokucu S, Kabukcuoglu Y, Kabukcuoglu F, Ozkaya U.
Sebuah etiologi langka dari equinismus: Hemangioma intramuskular (laporan kasus).
Buletin Medis Rumah Sakit Sisli Etfal. 2011.

D.7 Kilic A, Gul M, Sokucu S, Parmaksizoglu A, Kabukcuoglu Y.
Peran artroskopi dalam diagnosa dan pengobatan nyeri pergelangan tangan kronis.
Buletin Medis Rumah Sakit Sisli Etfal. 2009.

D.8 Kilic A, Gul M, Sokucu S, Mutlu H, Kabukcuoglu Y.
Evaluasi pengobatan terowongan karpal menggunakan Kuisioner Kepuasan Pasien (PEM).
Buletin Medis Rumah Sakit Sisli Etfal. 2009.

D.9 Sokucu S, Menges O, Gul M, Kabukcuoglu Y.
Dislokasi bahu bilateral anterior yang berkembang setelah trauma ringan selama latihan Pilates.
Buletin Medis Rumah Sakit Sisli Etfal. 2009.

D.10 Gul M, Ozkaya U, Parmaksizoglu A, Sokucu S, Kabukcuoglu Y.
Laporan kasus kista ganglion yang menyebabkan kelumpuhan kaki.
Buletin Medis Rumah Sakit Sisli Etfal. 2008.

D.11 Ozkaya U, Kabukcuoglu Y, Parmaksizoglu A, Kilic A, Sokucu S, Basilgan S.
Hasil reduksi terbuka dan fiksasi internal pada fraktur kalkaneus intra-artikular.
Jurnal Pelatihan dan Penelitian Kartal. 2007.

D.12 Gul M, Kilic A, Sokucu S, Yeniocak S, Kabukcuoglu Y.
Laporan kasus: Dislokasi siku ipsilateral dengan fraktur-disulokasi pergelangan tangan terkait.
Jurnal Pelatihan dan Penelitian Kartal. 2007.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Education

• (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
• (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

• (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Elnur Sahibov is a licensed Radiation Oncologist with 8 years of medical training and clinical experience. He completed his undergraduate and specialization studies at Marmara University Faculty of Medicine. From 2012 to 2016, he focused on advanced radiation oncology techniques.

Dr. Sahibov is known for his expertise in cancer treatment. He has helped improve patient outcomes and uses evidence-based protocols. He is accredited by leading medical institutions and is dedicated to ongoing professional development in oncology.